Physicochemical Properties
| Molecular Formula | C15H11N3 |
| Molecular Weight | 233.27 |
| Exact Mass | 235.111 |
| CAS # | 494-04-2 |
| Related CAS # | Nicotelline-d9;2469258-18-0 |
| PubChem CID | 68123 |
| Appearance | Brown to orange solid powder |
| Density | 1.168 g/cm3 |
| Boiling Point | 416.8ºC at 760 mmHg |
| Melting Point | 147-149ºC |
| Flash Point | 190.9ºC |
| Vapour Pressure | 9.02E-07mmHg at 25°C |
| Index of Refraction | 1.615 |
| LogP | 2.972 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 2 |
| Heavy Atom Count | 18 |
| Complexity | 256 |
| Defined Atom Stereocenter Count | 0 |
| InChi Key | OILSPHJMIPYURT-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C15H11N3/c1-3-13(10-16-6-1)12-5-8-18-15(9-12)14-4-2-7-17-11-14/h1-11H |
| Chemical Name | 2,4-dipyridin-3-ylpyridine |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| Targets | CYP26 ≥300 μM (Ki) |
| References |
[1]. Nicotine-related alkaloids and metabolites as inhibitors of human cytochrome P-450 2A6. Biochem Pharmacol. 2004 Feb 15;67(4):751-6. [2]. Nicotelline: a proposed biomarker and environmental tracer for particulate matter derived from tobacco smoke. Chem Res Toxicol. 2013 Nov 18;26(11):1615-31. |
| Additional Infomation | Nicotelline has been reported in Nicotiana tabacum with data available. |
Solubility Data
| Solubility (In Vitro) | DMSO: 100 mg/mL (428.69 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (10.72 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (10.72 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 4.2869 mL | 21.4344 mL | 42.8688 mL | |
| 5 mM | 0.8574 mL | 4.2869 mL | 8.5738 mL | |
| 10 mM | 0.4287 mL | 2.1434 mL | 4.2869 mL |